Capital Change Notice

Template
Capital Change Notice

Updated as at 17 October 2019


Section 1: Issuer information
Name of issuer Ryman Healthcare Limited
NZX ticker code RYM
Class of financial product Ordinary shares
ISIN (If unknown, check on NZX website) NZRYME0001S4
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 108,321,461 ordinary shares
Nominal value (if any) N/A
Issue/acquisition/redemption price per security $5.00
Nature of the payment (for example, cash or other
consideration)
Cash
Amount paid up (if not in full) Fully paid
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number
of Financial Products of the Class, excluding any
Treasury Stock, in existence)
21.358%
(calculated on the basis of
507,165,540 Financial Products on
issue prior to the allotment of new
shares on 24 February 2023 referred
to in this notice, being 504,671,258
ordinary shares quoted on the NZX
Main Board and 2,494,282 ordinary
shares held by the custodians under
Ryman Healthcare Limited's share
schemes)
For an issue of Convertible Financial Products or
Options, the principal terms of Conversion (for
example the Conversion price and Conversion date
and the ranking of the Financial Product in relation to
other Classes of Financial Product) or the Option (for
example, the exercise price and exercise date)
N/A
Reason for issue/acquisition/redemption and specific
authority for issue/acquisition/redemption/ (the reason
for change must be identified here)
Issue of new ordinary shares pursuant
to the Institutional Entitlement Offer
and Institutional Bookbuild
components of the pro-rata
accelerated entitlement offer
announced by Ryman Healthcare
Limited on 15 February 2023 (the
Offer), authorised by a Board
resolution dated 14 February 2023
Total number of Financial Products of the Class after
the issue/acquisition/redemption/Conversion
(excluding Treasury Stock) and the total number of
Financial Products of the Class held as Treasury Stock
after the issue/acquisition/redemption.
615,487,001 ordinary shares (including
2,494,282 ordinary shares held by the
custodians under Ryman Healthcare
Limited's share schemes)

In the case of an acquisition of shares, whether those
shares are to be held as treasury stock
N/A
Specific authority for the issue, acquisition, or
redemption, including a reference to the rule pursuant
to which the issue, acquisition, or redemption is made
Authorised by a resolution of the Board
dated 14 February 2023. The Offer is
made pursuant to NZX Listing Rule
4.3.1.
Terms or details of the issue, acquisition, or
redemption (for example: restrictions, escrow
arrangements)
The new ordinary shares issued will
rank equally with all other fully paid
ordinary shares in Ryman Healthcare
Limited.
Date of issue/acquisition/redemption 24/02/2023
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this
announcement
Deborah Marris
Contact person for this announcement
Deborah Marris
Contact phone number
+64 (0)27 222 1684
Contact email address
deborah.marris@rymanhealthcare.com
Date of release through MAP

24/02/2023